CMEInfo
- Programs in Medical Oncology (Sponsored Link)
|
Hematology and Medical Oncology Best Practices (55 hours). This program features a panel of hematology-medical oncology experts to help you prepare for your certification/recertification exam and aids practitioners evaluated through the ABMS Maintenance of Certification process, The self-study program lets you learn without the expense of travel or time away from your practice and repeat lectures as needed to reinforce learning of difficult topics.
|
CMEInfo
- Programs in Hematology (Sponsored Link)
|
Hematology and Medical Oncology Best Practices (55 hours). This program features a panel of hematology-medical oncology experts to help you prepare for your certification/recertification exam and aids practitioners evaluated through the ABMS Maintenance of Certification
process. The self-study program lets you learn without the expense of travel or time away from your practice and repeat lectures as needed to reinforce learning of difficult topics.
|
CMEInfo
Thrombosis and Thromboembolism
|
The Harvard
Thrombosis and Thromboembolism course provides an overview of
critical developments in the diagnosis, treatment, and prevention of
venous and arterial thromboembolic disorders. Areas covered are:
|
Osler Radiation Oncology Board Review (Sponsored Link) |
The Osler Radiation Oncology Board Review offers learning in a variety of venues and formats. |
Practical Reviews in Cancer Management |
Practical Reviews in Cancer Management |
Looking for more Cancer/Oncology Board Reviews or Cancer/Oncology Audio-Video CME? |
Visit ApolloCME.com (Cancer/Oncology) |
Looking for more Hematology/Oncology Board Reviews or Audio-Video CME? |
Visit ApolloCME.com (Hematology/Oncology) |
AML Tour (Cyberounds Acute Myeloid Leukemia in
the Elderly) |
The program is in the form of a bicycle tour game. Upon completion of this activity, you should be able to discuss the incidence, prevalence and survivor rates for adult AML (acute myeloid leukemia); discuss the advantages and disadvantages of available therapies for adult AML; discuss the results of clinical trials in adult AML; describe the role of PCR and FISH in diagnosis, treatment and follow-up; and describe the mechanisms of action of potential new treatments. |
Annenberg Center for Health Sciences at Eisenhower
|
Although the courses are spread out over a number of web sites, they are all sponsored by Annenberg. Plastic Surgery courses include: Perfecting the Use of Neurotoxins in Facial Aesthetics; Perioral Volume Correction: The Global Approach; and Differentiating Neurotoxins in Aesthetic Medicine. Hematology courses include: Evolving Strategies for Chronic Idiopathic Thrombocytopenic Purpura; Case Reviews in Porphyria and Case Reviews in Management of Myelodysplastic Syndrome. You will also find Glaucoma Medications – Impact of Preservatives on Safety and Stability. |
CA - A Cancer Journal for Clinicians
|
Some recent articles (2010 and 2009) are: Bladder Cancer in 2010; Exciting New Advances in Neuro-Oncology: Malignant Glioma; American Cancer Society Guideline for the Early Detection of Prostate Cancer; Developing a Quality Screening Colonoscopy Referral System in Primary Care Practice; Adult Cancer Survivorship: Evolution, Research, and Planning Care; Patient Decision Aids for Prostate Cancer Treatment: A Systematic Review of the Literature; Treating Tobacco Dependence in a Medical Setting; New Molecular Classifications of Breast Cancer; Preoperative Magnetic Resonance Imaging (MRI) in Breast Cancer; and Screening for Prostate Cancer. In order to take the quizzes, you must first obtain a username, password and customer number and then register with your personal information. |
Cancer Control: Journal of the Moffitt Cancer Center
|
This site contains full-text online versions of articles from a peer-reviewed cancer journal. Each issue focuses on one type of cancer and contains four or more major articles. A new issue comes out every two months. Currently, three of these issues offers CME credit: Chronic Lymphocytic Leukemia: Putting New Treatment Options Into Perspective; Iron Overload in Myelodysplastic Syndromes: Diagnosis and Management; and Enhancing Survival Outcomes in the Management of Patients With Higher-Risk Myelodysplastic Syndromes. Each module contains a set of 20 post-test questions; you need to score at least 75% to earn credit. |
CancerNetwork.com
|
You will find:
|
Cleveland
Clinic Hematology/Oncology
|
Some recent activities include: MDS and AML Therapeutic Strategies: Similarities, Differences, and Overlap; Patient Involvement in Personalizing Therapy; Clinical Implications: Applying MDS Therapies to AML Patients and Vice-Versa; Biologics III: The Newer Agents; and Driven Management of Rheumatoid Arthritis. |
Clinical
Care Options Oncology
|
About 40 text-based or case-based-interactive
activities concerned
with aspects of cancer. All of these categories offer CME credit:
Conference Coverage, Journal Options, Management Series, Treatment
Updates,
Annual Updates and Interactive Cases.
|
CME Credits Online
|
A single presentation, New Developments with Targeted Therapies for Patients with Advanced Renal Cell Cancer.
After viewing this course, you should be able to:
|
CME LLC Oncology
|
19 e-Updates offering 0.5 to 3.0 credits each (total of about 30 hours).
Recent topics include: Lung Cancer; Ovarian Cancer; Colorectal Cancer; Pancreatic Cancer and Breast Cancer.
|
Emerging Management Strategies for Chronic Lymphocytic Leukemia in High-Risk Patients
|
Upon completion of this activity, you should be able to:
|
GliomaEd.com
|
A series of about 20 activities on the diagnosis and treatment of glioma and glioblastoma. |
HITeducation.com
|
HITeducation.com focuses on heparin-induced thrombocytopenia (HIT) risk factors, presentation, diagnosis and management, and
therapeutic options.
|
Hollywood Arcade (Cyberounds -
Metastatic Breast Cancer)
|
The instruction is presented in the form of a pinball game. After completing this activity, you should be able to: discuss the current management of taxane-resistant metastatic breast cancer; describe recent clinical trials involving newer taxanes and newer chemotherapy (e.g., capecitabine); describe recent clinical trials involving novel agents, e.g., epothilones, as monotherapy or in combination with capecitabine for the treatment of taxane-resistant, metastatic breast cancer; and discuss the mechanisms of action of the various proposed new agents. |
Imedex eLearning Center
|
A variety of courses in oncology. Most activities (43) in Oncology; other areas are Hematology (22), Gastroenterology (3), Infectious Disease (1) and Dermatology (2). |
InforMEDical
Oncology CME
|
Five programs currently offered: Novel Agents in the Treatment of Lung Cancer: New Approaches to First-Line Therapy; Lung Cancer: Case Studies Assessing Novel Agents in First-Line Therapy; Lung Cancer: Assessing Maintenance and Early Second-Line Therapies; Colon and Rectal Cancers: Pathologic Staging and Assessment; and Innovations and Challenges in Renal Cancer. |
ITPeducation.org
|
ITPeducation.org focuses on managing patients with ITP and related thrombocytopenic complications.
There are 4 sections:
|
Johns Hopkins Advanced Studies in Oncology
|
This site promises CME activities concerning a wide variety of cancers, but only 4 activities are in fact present. They are: Case-Based Discussion of Emerging Evidence: Comprehensive Treatment Planning for Patients with High-Grade Gliomas (Journal Club); Case-Based Discussion of Emerging Evidence: Comprehensive Treatment Planning for Patients with High-Grade Gliomas; Monograph - Perspectives In Central Nervous System Malignancies; and Podcasts - Perspectives In Central Nervous System Malignancies. |
Managing Myeloma
|
After registering and logging in, click on Education to find these activities:
|
Medscape
Hematology-Oncology
|
CME activities of special interest to hematologists and oncologists. Medscape contains a variety of educational formats:
|
MelanomaCare.org
|
You will find 13 webcasts/podcasts; the newest are: The Management of In-Transit Melanoma; Current Status of Adjuvant Interferon-α (IFN-α) Therapy in Melanoma; The Role of Sentinel Lymph Node Biopsy (SLNB) in Prior Resected and Recurrent Melanoma; Immunotherapy of Melanoma Using Checkpoint Blockade; and Melanoma Brain Metastases. You will also find a single text publication, Update on Advances in Melanoma: Current Progress and Future Promise. |
Meniscus Limited
|
There are 2 activities at this time: CINV (chemotherapy-induced nausea and vomiting): Using Evidence-Based Practice to Improve Patient Outcomes; and Systemic Chemotherapy for Breast Cancer: Issues in Preoperative and Adjuvant Treatment. |
MyCME.com Oncology Courses from Johns Hopkins
|
One new course per month. Recent activities include: Non-Small Cell Lung Cancer Management based on EGFR Mutation Status; Colorectal Cancer and Evidence for Cure by Adjuvant Chemotherapy; Oncofertility in Clinical Practice; Evidence for the Use of Circulating Tumor Cells in the Prognostic Stratification of Women with Metastatic Breast Cancer; and Carcinoma of Unknown Primary: Changing Paradigm in the Era of Molecular Profiling. |
NSCLCeducation.org
|
NSCLCeducation.org is a set of activities designed to help you to diagnose and treat non-small cell lung cancer (NSCLC).
|
New Paradigms for Systemic Therapy in Advanced/Metastatic Non-Small Cell Lung Cancer
|
After completing this activity, you should be able to:
|
(The)
Oncologist
|
"Over 200" courses in a wide variety of hematology and oncology areas. Some major areas are: Acute and Chronic Leukemias and Multiple Myeloma; Breast Cancer; Cancer Biology; Clinical Pharmacology; Gastrointestinal Cancer; Genitourinary Cancer; Lung Cancer; Lymphoma; Radiation Oncology; Schwartz Center Rounds; and Symptom Management and Supportive Care. Some newer activities are: Contemporary Imaging in Sarcoma; The Assessment and Management of Delirium in Cancer Patients; Plasma Fibrinogen Levels and Prognosis in Patients with Ovarian Cancer; and Should Patients With High-Risk Soft Tissue Sarcoma Receive Adjuvant Chemotherapy? |
OptumHealth
Education
|
The slide-video lectures currently available are in the following areas: Cardiology (12), Diabetes(2), Infectious Disease (2), Gastroenterology (5), Neuroscience (32), and Oncology (9). |
Practical Reviews in Cancer Management |
Practical Reviews in Cancer Management |
prIME Oncology Web Activities
|
Not all activities offer CME credit. Some recent activities offering CME
credit are:
|
Projects
In Knowledge Advanced Certificate Program: Breast Cancer Management
II
|
After completing this program, you should be able to: apply evidence-based guidelines to determine optimal treatment interventions for patients with or at risk for developing breast cancer through an understanding of the epidemiology, risk factors, and disease burden imposed by breast cancer, including genetic factors, dietary modification, morbidity, and mortality; assess the role of genetic and other markers in determining optimal treatment selection in breast cancer patients, and in evaluating treatment response to therapy to improve patient outcomes; evaluate the appropriate use of chemotherapy, hormone therapy, and targeted therapy agents in treatment strategies for breast cancer patients that improve outcomes through knowledge of their efficacy and safety; and assess the challenges in promoting treatment compliance, including long-term compliance, and address the long-term consequences of treatment. |
Projects
In Knowledge Advanced Certificate Program in Hepatocellular Carcinoma
|
After completing this course, you should be able to: assess the importance of screening, surveillance, diagnosis, and optimal treatment intervention of patients with or at risk of developing HCC (hepatocellular carcinoma) through an understanding of the risk factors, disease burden, imaging, and biomarkers to customize interventions leading to improved patient outcomes; analyze the benefits of liver transplantation, surgical resection and ablation therapies in eligible patients with HCC to optimize patient outcomes; compare the benefits of various adjunctive therapies, including ablative therapy, radiofrequency ablation (RFA) and chemoembolization; as well as conformal or stereotactic radiation, including radiotherapeutic microspheres, to select single or combined strategies that improve outcomes of patients with HCC; evaluate the benefits of targeted therapeutic agents, based on their efficacy and safety profiles and mechanisms of action, to improve treatment outcomes in patients with HCC; assess tumor- and patient-related factors as predictors of response to determine which patients with HCC are likely to benefit from specific therapies to improve their outcomes; and describe the potential role of systemic chemotherapies in combination with targeted agents, in the future treatment of patients with HCC. |
Projects In Knowledge Advanced Certificate Program: Lung Cancer Management
II
|
This 12-month curriculum explores both non-small-cell lung cancer (NSCLC) as well as small cell lung cancer (SCLC) with respect to Guidelines, Assessing at-risk individuals, Screening, Diagnosis, Staging and Treatment. Current and emerging innovative treatment options and strategies in lung cancer are emphasized, such as chemotherapy (including newer agents such as paclitaxel, pralatrexate and talotrexin), chemoradiation, neoadjuvant and adjuvant chemotherapy), consolidative chemotherapy, targeted therapies (including vascular endothelial growth factor [VEGF] inhibitors, epidermal growth factor [EGFR] inhibitors, matrix metalloprotease (MMP) inhibitors, farnesyl transferase [FT] inhibitors, multikinase inhibitors, inhibitors of Ras, HDAC, mTOR, Met, MEK, toll and p13K, that include gefitinib, erlotinib, bevacizumab, sunitinib, sorafenib, lonafarnib, vandetanib and cetuximab). |
Projects
In Knowledge Certificate Program in
Advanced/Metastatic Colorectal Cancer
|
After completing this program, you should be able to: determine the importance of environmental, dietary, and hereditary risk factors associated with the development of colorectal cancer; analyze the guidelines/recommendations and options for treatment of patients with stage two and stage three colon and rectal cancer; assess the first-line and subsequent treatment options available for patients with metastatic colorectal cancer; and evaluate the options available for multimodal management of patients with resectable metastatic colorectal cancer.
|
Projects In Knowledge Living Medical Textbook Hematology Edition: Insights into Managing Leukemia
|
Three chapters at present: Overview of Leukemia; Lymphoid Leukemia; and Myeloid Leukemia. |
Society of Gynecologic Oncologists 41st Annual Meeting on Women's Cancer
|
This website features selected lectures from the 41st annual meeting, held in San Francisco in March 2010. Not all sessions offer CME credit and I could not find the total number of hours or the number of hours per session. Some topics are: Fertility-preserving treatment in young patients with endometrial carcinoma and atypical hyperplasia; Progression-free survival and overall survival in patients diagnosed with stage III/IV ovarian cancer and treated with primary surgery or neoadjuvant chemotherapy with or without delayed debulking surgery; Neoadjuvant Chemotherapy; and Lymph Node Dissection in Ovarian Cancer. |
Texas
Medical Association’s Physician Oncology Education Program (POEP)
|
The seven activities are: Ovarian Cancer, pdf version (1.5 hours); Ovarian Cancer: Designed for the Primary Care Physician (online module) (1.0 hour); Pain Primer for Primary Physicians: Essential Concepts (1.5 hours); Performance Improvement (PI) Continuing Medical Education Project for Primary Care Physicians (20 hours, fee not stated); Potential Endocrine Effects of Anticancer Therapy (1.5 hours); Tobacco Intervention and the Health Care Provider (1.0 hour); and Survivorship (Lance Armstrong Foundation: Professional Training Opportunities) (probably no CME credit) |
VTEeducation.com
|
VTEeducation.com focuses on
"promoting better thromboprophylaxis... through adherence to evidence-based guidelines and appropriate use of all available therapies."
|